SEC Form 4 · accession 0001179110-17-000844
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ganesh Venkataraman Kaundinya
Officer — Senior V.P., Research
Period of report
Jan 9, 2017
Accepted (ET)
Jan 10, 2017 · 3:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2017 | M | 15,000 | $12.81 | A | 469,015 | D | |
| Common Stock | Jan 9, 2017 | M | 24,647 | $7.41 | A | 493,662 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $12.81 | Jan 9, 2017 | M | 15,000 | D | Feb 22, 2011 | Feb 22, 2017 | Common Stock | 15,000 | 0 | D |
| Stock Option (Right to Buy) | $7.41 | Jan 9, 2017 | M | 24,647 | D | Feb 22, 2012 | Feb 22, 2018 | Common Stock | 24,647 | 0 | D |